Følgende generelle metoder er opptatt i Ph. Eur. pr. 1. juli 2017.

Nye tekster

KapittelNavn
5.1.11.Determination of bactericidal, fungicidal or yeasticidal activity of antiseptic medicinal products

Reviderte tekster

KapittelNavn
2.2.1.Clarity and degree of opalescence of liquids
2.6.27.Microbiological examination of cell-based preparations
2.6.30.Monocyte-activation test
3.1.3.Polyolefins
3.1.4.Polyethylene without additives for containers for parenteral preparations and for ophthalmic preparations
3.1.5.Polyethylene with additives for containers for parenteral preparations and for ophthalmic preparations
3.1.6.Polypropylene for containers and closures for parenteral preparations and ophthalmic preparations
3.1.7.Poly(ethylene - vinyl acetate) for containers and tubing for total parenteral nutrition preparations
4.Reagents (nye, endrede og korrigerte)
5.1.1.Methods of preparation of sterile products
5.1.2.Biological indicators and related microbial preparations used in the manufacture of sterile products
5.1.6.Alternative methods for control of microbiological quality
5.8.Pharmacopoeial harmonisation
5.15.Functionality-related characteristics of excipients
5.22.Names of herbal drugs used in traditional Chinese medicine

 
Følgende generelle metoder var opptatt i Ph. Eur. pr. 1. april 2017.

Nye tekster

KapittelNavn
2.6.34.Host-cell protein assay

Reviderte tekster

KapittelNavn
2.2.14.Melting point – capillary method
2.7.5.Assay of heparin
2.9.14.Specific surface area by air permeability
2.9.40.Uniformity of dosage units
4.Reagents (nye, endrede og korrigerte)
5.8.Pharmacopoeial harmonisation
5.22.Names of herbal drugs used in traditional Chinese medicine

 
Følgende generelle metoder var opptatt i Ph. Eur. pr. 1. januar 2017.

Nye tekster

KapittelNavn
2.7.35.Immunoephelometry for vaccine component assay
2.8.25.High-performance thin-layer chromatography of herbal drugs and herbal drug preparations
5.2.12.Raw materials of biological origin for the production of cell-based and gene therapy medicinal products
5.2.13.Healthy chicken flocks for the production of inactivated vaccines for veterinary use

Reviderte tekster

KapittelNavn
2.4.24.Identification and control of residual solvents
2.5.28.Water in gases
2.9.6.Uniformity of content of single-dose preparations
4.Reagents (nye, endrede og korrigerte)
5.2.3.Cell substrates for the production of vaccines for human use
5.8.Pharmacopoeial harmonisation

Publisert: 03.07.2017